$UPXI
UPEXI, INC. Stock $upxi

$upxi Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000147793224008219 Filed on December 19, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$4.357M
YoY Change	-84.07%
Cost Of Revenue	$1.426M
YoY Change	-92.35%
Gross Profit	$2.930M
YoY Change	-66.35%
Gross Profit Margin	67.26%
Selling, General & Admin	$2.409M
YoY Change	-52.8%
% of Gross Profit	82.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$239.9K
YoY Change	-16.14%
% of Gross Profit	8.19%
Operating Expenses	$4.265M
YoY Change	-56.7%
Operating Profit	-$1.335M
YoY Change	16.9%
Interest Expense	$290.4K
YoY Change	-133.22%
% of Operating Profit
Other Income/Expense, Net	-$290.4K
YoY Change	-133.22%
Pretax Income	-$1.626M
YoY Change	19.85%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$1.626M
YoY Change	19.85%
Net Earnings / Revenue	-37.31%
Basic Earnings Per Share	-$1.55
Diluted Earnings Per Share	-$1.55
COMMON SHARES
Basic Shares Outstanding	20.89M shares
Diluted Shares Outstanding	1.045M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$661.4K
YoY Change		-85.27%
Cash & Equivalents	$1.790M	$661.4K
Short-Term Investments		$0.00
Other Short-Term Assets
YoY Change
Inventory	$1.636M	$1.432M
Prepaid Expenses
Receivables	$801.4K	$606.9K
Other Receivables
Total Short-Term Assets	$6.790M	$11.42M
YoY Change	-72.75%	-55.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.338M	$2.357M
YoY Change	-69.81%	-68.69%
Goodwill	$848.9K	$848.9K
YoY Change	-92.76%	-91.72%
Intangibles	$220.7K	$239.9K
YoY Change	-98.22%	-98.23%
Long-Term Investments
YoY Change
Other Assets	$206.4K	$278.4K
YoY Change	-43.47%	187.85%
Total Long-Term Assets	$11.81M	$12.09M
YoY Change	-70.71%	-68.51%
TOTAL ASSETS
Total Short-Term Assets	$6.790M	$11.42M
Total Long-Term Assets	$11.81M	$12.09M
Total Assets	$18.60M	$23.51M
YoY Change	-71.49%	-63.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$575.2K	$481.6K
YoY Change	-87.6%	-87.87%
Accrued Expenses	$317.2K	$736.4K
YoY Change	-91.83%	-78.12%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$9.771M	$12.66M
YoY Change	-51.23%	-35.45%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$3.800M	$4.340M
YoY Change	-78.46%	-73.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.771M	$12.66M
Total Long-Term Liabilities	$3.800M	$4.340M
Total Liabilities	$13.57M	$17.00M
YoY Change	-63.98%	-52.81%
SHAREHOLDERS EQUITY
Retained Earnings	-$48.49M	-$46.86M
YoY Change	97.43%	101.97%
Common Stock	$20.91K	$19.86K
YoY Change	2.94%	-1.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.032M	$6.516M
YoY Change
Total Liabilities & Shareholders Equity	$18.60M	$23.51M
YoY Change	-71.49%	-63.18%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$1.626M
YoY Change	19.85%
Depreciation, Depletion And Amortization	$239.9K
YoY Change	-16.14%
Cash From Operating Activities	-$1.975M
YoY Change	-15.77%
INVESTING ACTIVITIES
Capital Expenditures	$167.4K
YoY Change	-43.5%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$5.838M
YoY Change	-999.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$2.735M
YoY Change	152.68%
NET CHANGE
Cash From Operating Activities	-$1.975M
Cash From Investing Activities	$5.838M
Cash From Financing Activities	-$2.735M
Net Change In Cash	$1.129M
YoY Change	-129.31%
FREE CASH FLOW
Cash From Operating Activities	-$1.975M
Capital Expenditures	$167.4K
Free Cash Flow	-$2.142M
YoY Change	-18.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	661415	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	606885	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	390810	usd
CY2024Q3	upxi	Purchase Price Receivable E Core Current PurchasePriceReceivableECoreCurrent	0	usd
CY2024Q2	upxi	Purchase Price Receivable E Core Current PurchasePriceReceivableECoreCurrent	2000000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	6790280	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	11419918	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2338199	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2356556	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	220681	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	239871	usd
CY2024Q2	us-gaap	Goodwill Goodwill	848854	usd
CY2024Q3	us-gaap	Goodwill Goodwill	848854	usd
CY2024Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5948858	usd
CY2024Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5948858	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	206360	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	278435	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2249796	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2418596	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	12091170	usd
CY2024Q3	us-gaap	Assets Assets	18603028	usd
CY2024Q2	us-gaap	Assets Assets	23511088	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	575238	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	481647	usd
CY2024Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	952601	usd
CY2024Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1098856	usd
CY2024Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	178016	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	235255	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	317239	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	736407	usd
CY2024Q3	us-gaap	Interest Payable Current InterestPayableCurrent	453280	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	476018	usd
CY2024Q2	upxi	Portion Of Acquisition Note Payable PortionOfAcquisitionNotePayable	413152	usd
CY2024Q3	upxi	Portion Of Acquisition Note Payable PortionOfAcquisitionNotePayable	413152	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2024Q2	upxi	Notes Payable Related Party NotesPayableRelatedParty	100000	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	140000	usd
CY2024Q3	upxi	Notes Payable Related Party NotesPayableRelatedParty	0	usd
CY2024Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	387500	usd
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	usd
CY2024Q3	upxi	Current Portion Of Related Party Note Payable CurrentPortionOfRelatedPartyNotePayable	125000	usd
CY2024Q2	upxi	Current Portion Of Related Party Note Payable CurrentPortionOfRelatedPartyNotePayable	0	usd
CY2024Q2	upxi	Notes Payable Cygnet Subsidiary Current NotesPayableCygnetSubsidiaryCurrent	5447565	usd
CY2024Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	0	usd
CY2024Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2634538	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1031714	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	12655152	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1842505	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1732606	usd
CY2024Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	500000	usd
CY2024Q3	us-gaap	Notes Payable NotesPayable	420000	usd
CY2024Q2	us-gaap	Notes Payable NotesPayable	557429	usd
CY2024Q3	us-gaap	Convertible Debt ConvertibleDebt	1162500	usd
CY2024Q2	us-gaap	Convertible Debt ConvertibleDebt	1550000	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3800005	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4340035	usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	25	usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	25	usd
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1045429	shares
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	53515742	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	53374444	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48485190	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-46859613	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18603028	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23511088	usd
CY2024Q3	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">Reclassifications</span></strong><strong> - </strong>Certain reclassifications have been made to the consolidated financial statements as of and for the three months ended September 30, 2023 to conform to the presentation as of and for the three months ended September 30, 2024.</p>
CY2024Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001775194
CY2024Q3	dei	Amendment Flag AmendmentFlag	false
CY2024Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	25000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	25000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1045429	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1045429	shares
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	61750	usd
CY2024Q3	dei	Document Type DocumentType	10-Q
CY2024Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2024Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	dei	Entity File Number EntityFileNumber	001-40535
CY2024Q3	dei	Entity Registrant Name EntityRegistrantName	UPEXI, INC.
CY2024Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-3378978
CY2024Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	3030 North Rocky Point Drive
CY2024Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Tampa
CY2024Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33607
CY2024Q3	dei	City Area Code CityAreaCode	701
CY2024Q3	dei	Local Phone Number LocalPhoneNumber	353-5425
CY2024Q3	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001
CY2024Q3	dei	Trading Symbol TradingSymbol	UPXI
CY2024Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q3	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2024Q3	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1040924	shares
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1790391	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	801442	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	1636419	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	1431556	usd
CY2024Q3	upxi	Related Party Transaction Due From To Related Parties RelatedPartyTransactionDueFromToRelatedParties	171218	usd
CY2024Q2	upxi	Related Party Transaction Due From To Related Parties RelatedPartyTransactionDueFromToRelatedParties	212358	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	502188	usd
CY2024Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	0	usd
CY2024Q2	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	4005516	usd
CY2024Q2	upxi	Purchase Price Receivable Vitamedica Current PurchasePriceReceivableVitamedicaCurrent	2000000	usd
CY2024Q3	upxi	Purchase Price Receivable Vitamedica Current PurchasePriceReceivableVitamedicaCurrent	2000000	usd
CY2024Q3	us-gaap	Other Assets OtherAssets	11812748	usd
CY2024Q3	upxi	Notes Payable Cygnet Subsidiary Current NotesPayableCygnetSubsidiaryCurrent	5447565	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	781810	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	9771401	usd
CY2024Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	375000	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	25000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	25000	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1045429	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	1045	usd
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	1045	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	5031622	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	6515901	usd
CY2024Q3	us-gaap	Revenues Revenues	4356515	usd
CY2023Q3	us-gaap	Revenues Revenues	8274690	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	1426447	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	2845201	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	2930068	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	5429489	usd
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1041425	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1816702	usd
CY2024Q3	us-gaap	Production And Distribution Costs ProductionAndDistributionCosts	1455725	usd
CY2023Q3	us-gaap	Production And Distribution Costs ProductionAndDistributionCosts	2131892	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1367690	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1578350	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	141298	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	421887	usd
CY2024Q3	upxi	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	19190	usd
CY2023Q3	upxi	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	658858	usd
CY2024Q3	us-gaap	Depreciation Depreciation	239905	usd
CY2023Q3	us-gaap	Depreciation Depreciation	277613	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	4265233	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	6885302	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1335165	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1455813	usd
CY2024Q3	upxi	Other Incom Expenses Net OtherIncomExpensesNet	0	usd
CY2023Q3	upxi	Other Incom Expenses Net OtherIncomExpensesNet	-9808	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	290412	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	843475	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-290412	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-853283	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1625577	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2309096	usd
CY2024Q3	upxi	Income Tax Expense Benefit Gross IncomeTaxExpenseBenefitGross	0	usd
CY2023Q3	upxi	Income Tax Expense Benefit Gross IncomeTaxExpenseBenefitGross	472367	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	472367	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1625577	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1836729	usd
CY2024Q3	upxi	Gain From The Sale Of Interactive Offers GainFromTheSaleOfInteractiveOffers	0	usd
CY2023Q3	upxi	Gain From The Sale Of Interactive Offers GainFromTheSaleOfInteractiveOffers	380624	usd
CY2024Q3	upxi	Gain Loss From The Sale Of Interactive Offers Net GainLossFromTheSaleOfInteractiveOffersNet	0	usd
CY2023Q3	upxi	Gain Loss From The Sale Of Interactive Offers Net GainLossFromTheSaleOfInteractiveOffersNet	380624	usd
CY2024Q3	upxi	Income Loss On Discontinued Operations Interactive Offers IncomeLossOnDiscontinuedOperationsInteractiveOffers	0	usd
CY2023Q3	upxi	Income Loss On Discontinued Operations Interactive Offers IncomeLossOnDiscontinuedOperationsInteractiveOffers	-193040	usd
CY2024Q3	upxi	Income Loss On Discontinued Operations Vitamedica IncomeLossOnDiscontinuedOperationsVitamedica	0	usd
CY2023Q3	upxi	Income Loss On Discontinued Operations Vitamedica IncomeLossOnDiscontinuedOperationsVitamedica	69406	usd
CY2024Q3	upxi	Gain Loss From The Sale Of E Core GainLossFromTheSaleOfECore	0	usd
CY2023Q3	upxi	Gain Loss From The Sale Of E Core GainLossFromTheSaleOfECore	224351	usd
CY2024Q3	upxi	Income Loss On Discontinued Operations Infuisionz IncomeLossOnDiscontinuedOperationsInfuisionz	0	usd
CY2023Q3	upxi	Income Loss On Discontinued Operations Infuisionz IncomeLossOnDiscontinuedOperationsInfuisionz	100717	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1625577	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1355388	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.55
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.81
CY2024Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.10
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.55
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.34
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.55
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.81
CY2024Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.10
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.55
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.34
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1045429	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1012231	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1045429	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1012231	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	27836623	usd
CY2023Q3	upxi	Issuance Of Stock And Equity For Purchase Of Cygnet Amount IssuanceOfStockAndEquityForPurchaseOfCygnetAmount	667874	usd
CY2023Q3	upxi	Stock Based Compensation Amortization Of Stock Options StockBasedCompensationAmortizationOfStockOptions	421887	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1355388	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	27570996	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	6515901	usd
CY2024Q3	upxi	Stock Based Compensation Amortization Of Stock Options StockBasedCompensationAmortizationOfStockOptions	141298	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1625577	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	5031622	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	1625577	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	1355388	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	259095	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	936471	usd
CY2024Q3	upxi	Amortization Of Loan Costs AmortizationOfLoanCosts	2571	usd
CY2023Q3	upxi	Amortization Of Loan Costs AmortizationOfLoanCosts	23708	usd
CY2024Q3	upxi	Amortization Of Consideration Discount AmortizationOfConsiderationDiscount	0	usd
CY2023Q3	upxi	Amortization Of Consideration Discount AmortizationOfConsiderationDiscount	363412	usd
CY2024Q3	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	0	usd
CY2023Q3	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	472367	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	141298	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	421887	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	194557	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1323364	usd
CY2024Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	204863	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1856684	usd
CY2024Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-170455	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-306369	usd
CY2024Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	28795	usd
CY2023Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-63022	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-494570	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	925927	usd
CY2024Q3	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-57239	usd
CY2023Q3	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	19819	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1974592	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2073232	usd
CY2024Q3	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	0	usd
CY2023Q3	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1718972	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1974592	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3792204	usd
CY2024Q3	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	4005516	usd
CY2023Q3	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	0	usd
CY2024Q3	upxi	Proceeds From The Sale Of E Core ProceedsFromTheSaleOfECore	2000000	usd
CY2023Q3	upxi	Proceeds From The Sale Of E Core ProceedsFromTheSaleOfECore	0	usd
CY2024Q3	upxi	Proceeds From The Sale Of Interactive Offers Net Of Liabilities Paid ProceedsFromTheSaleOfInteractiveOffersNetOfLiabilitiesPaid	0	usd
CY2023Q3	upxi	Proceeds From The Sale Of Interactive Offers Net Of Liabilities Paid ProceedsFromTheSaleOfInteractiveOffersNetOfLiabilitiesPaid	940000	usd
CY2024Q3	us-gaap	Payments To Acquire Business Three Net Of Cash Acquired PaymentsToAcquireBusinessThreeNetOfCashAcquired	0	usd
CY2023Q3	us-gaap	Payments To Acquire Business Three Net Of Cash Acquired PaymentsToAcquireBusinessThreeNetOfCashAcquired	500000	usd
CY2024Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	167410	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	294676	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	5838106	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	145324	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5838106	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	145324	usd
CY2024Q3	upxi	Payments To Acquire Notes Payable PaymentsToAcquireNotesPayable	0	usd
CY2023Q3	upxi	Payments To Acquire Notes Payable PaymentsToAcquireNotesPayable	265569	usd
CY2024Q3	upxi	Proceeds From Advances From Related Parties ProceedsFromAdvancesFromRelatedParties	-100000	usd
CY2023Q3	upxi	Proceeds From Advances From Related Parties ProceedsFromAdvancesFromRelatedParties	0	usd
CY2024Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2634538	usd
CY2023Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	60373	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-2734538	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-325942	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2734538	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-325942	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1128976	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2253850	usd
CY2024Q3	upxi	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDiscontinuedOperations	0	usd
CY2023Q3	upxi	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDiscontinuedOperations	-1718972	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	661415	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4492291	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1790391	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	519469	usd
CY2024Q3	us-gaap	Interest Paid Net InterestPaidNet	84362	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	94860	usd
CY2024Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2024Q3	upxi	Common Stock Issued For Acquisition Of Cygnet CommonStockIssuedForAcquisitionOfCygnet	0	usd
CY2023Q3	upxi	Common Stock Issued For Acquisition Of Cygnet CommonStockIssuedForAcquisitionOfCygnet	162727	usd
CY2024Q3	upxi	Debt Issued For Acquisition Of Cygnet DebtIssuedForAcquisitionOfCygnet	0	usd
CY2023Q3	upxi	Debt Issued For Acquisition Of Cygnet DebtIssuedForAcquisitionOfCygnet	300000	usd
CY2024Q3	upxi	Net Bloomios Non Cash Payment Of Receivables NetBloomiosNonCashPaymentOfReceivables	0	usd
CY2023Q3	upxi	Net Bloomios Non Cash Payment Of Receivables NetBloomiosNonCashPaymentOfReceivables	845443	usd
CY2024Q3	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 1. Background Information</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As used in this quarterly report and unless otherwise indicated, the terms “we”, “us”, “our”, “Upexi”, and the “Company” mean Upexi, Inc., a Nevada corporation formed in 2018. The Company has eleven active subsidiaries, which include:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐</p></td><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">HAVZ, LLC, d/b/a/ Steam Wholesale, a California limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐ </p></td><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Gummy Labs, LLC, a Delaware limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐</p></td><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">MW Products, Inc., a Nevada corporation</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐</p></td><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upexi Holding, LLC, a Delaware limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">o</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upexi Pet Products, LLC, a Delaware limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐</p></td><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upexi Enterprise, LLC, a Delaware limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">o</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upexi Distribution LLC, a Delaware limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">o</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upexi Distribution Management LLC, a Delaware limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">o</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upexi Property & Assets, LLC, a Delaware limited liability company</p></td></tr><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">■</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upexi 17129 Florida, LLC, a Delaware limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐</p></td><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cygnet Online, LLC (“Cygnet”), a Delaware limited liability company (100% owned as of September 1, 2023)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following subsidiaries had no activity during the three months ended September 30, 2024 and 2023:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upexi CP, LLC, a Delaware limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐ </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upexi CP / Canada Inc., a Canadian corporation</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Prax Products, LLC, a Florida limited liability company </p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upexi Development and Marketing, LLC., a Delaware limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Trunano Labs, Inc., a Nevada corporation</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following subsidiaries were divested during the year ended June 30, 2024 and all activity for the three months ended September 30, 2023 was classified as discontinued operations:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">VitaMedica, Inc. a Nevada corporation</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐ </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">E-Core Technology, Inc. a Florida corporation</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Interactive Offers, LLC, a Delaware limited liability company</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition, the Company has six wholly owned subsidiaries that had no activity during the three months ended September 30, 2023. All of the entities were dissolved or cancelled as of June 30, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Steam Distribution, LLC, a California limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">One Hit Wonder, Inc., a California corporation</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">One Hit Wonder Holdings, LLC, a California limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Vape Estate, Inc., a Nevada Corporation</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">SWCH, LLC, a Delaware limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cresco Management, LLC, a California limited liability company</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our products are distributed in the United States of America and internationally through multiple entities and managed through our locations in Florida.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Upexi</strong> operates from our corporate location in Tampa, Florida, where direct to consumer, wholesale and Amazon sales are driven by on-site and remote teams for all brands. The Tampa location also supports all the other locations with accounting, corporate oversight, day-to-day finances, business development and operational management operating from this location. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>MW Products </strong>operates from our corporate headquarters and our Tampa, Florida warehouse, managing direct to consumer, wholesale and Amazon sales for multiple brands and developing new products through our research and development team in Henderson, Nevada and Odessa, Florida.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Lucky Tail</strong> operates from our Tampa, Florida warehouse with sales and marketing driven by on-site and remote teams that operate the Amazon sales strategy and daily business operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>HAVZ, LLC, d/b/a/ Steam</strong> <strong>Wholesale</strong> operates manufacturing and/or distribution centers in Odessa, Florida, supporting our health and wellness products, including those products manufactured with hemp ingredients and our overall distribution operations. We have continued to manage these operations with corporate focus on larger opportunities that have warranted the majority of corporate focus and investments for the future.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Upexi Distribution </strong>operates from our Tampa, Florida warehouse providing warehousing, distribution and other services in support of our product sales. </p>
CY2024Q3	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">Use of Estimates</span></strong> <strong>-</strong> The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Significant estimates underlying the Company’s reported financial position and results of operations include the allowance for doubtful accounts, useful lives of property and equipment, impairment of long-lived assets, inventory valuation, fair value of stock-based compensation and valuation allowance on deferred tax assets.</p>
CY2024Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	801452	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	606885	usd
CY2023Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	2605958	usd
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	1125394	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	61750	usd
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	497160	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1139259	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	465535	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	966021	usd
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	605994	usd
CY2024Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	605470	usd
CY2023Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	65994	usd
CY2024Q3	us-gaap	Sale Leaseback Transaction Lease Term SaleLeasebackTransactionLeaseTerm	P5Y
CY2024Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	3594745	usd
CY2023Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2889158	usd
CY2024Q3	upxi	Revenue From Primary Geographical Markets United States Of America RevenueFromPrimaryGeographicalMarketsUnitedStatesOfAmerica	4280593	usd
CY2023Q3	upxi	Revenue From Primary Geographical Markets United States Of America RevenueFromPrimaryGeographicalMarketsUnitedStatesOfAmerica	8162728	usd
CY2024Q3	upxi	Revenue From Primary Geographical Markets Other RevenueFromPrimaryGeographicalMarketsOther	75922	usd
CY2023Q3	upxi	Revenue From Primary Geographical Markets Other RevenueFromPrimaryGeographicalMarketsOther	111962	usd
CY2024Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	4356515	usd
CY2023Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	8274690	usd
CY2024Q3	upxi	Total Disaggregated Revenue TotalDisaggregatedRevenue	4356515	usd
CY2023Q3	upxi	Total Disaggregated Revenue TotalDisaggregatedRevenue	8274690	usd
CY2024Q3	us-gaap	Deferred Revenue DeferredRevenue	178016	usd
CY2024Q2	us-gaap	Deferred Revenue DeferredRevenue	235255	usd
CY2024Q3	us-gaap	Deferred Revenue DeferredRevenue	178016	usd
CY2024Q2	us-gaap	Deferred Revenue DeferredRevenue	235255	usd
CY2024Q3	upxi	Revenue Revenue	210000	usd
CY2024Q3	us-gaap	Advertising Expense AdvertisingExpense	194774	usd
CY2023Q3	us-gaap	Advertising Expense AdvertisingExpense	287146	usd
CY2024Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6535000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6100000	usd
CY2024Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	19860	usd
CY2024Q3	upxi	Additional Issuance Shares AdditionalIssuanceShares	38	shares
CY2024Q3	upxi	Additional Issuance Shares Of Common Stock AdditionalIssuanceSharesOfCommonStock	202183	shares
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	497160	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	465535	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1139259	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	966021	usd
CY2024Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent	1636419	usd
CY2024Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	1431556	usd
CY2024Q3	us-gaap	Inventory Write Down InventoryWriteDown	42370	usd
CY2023Q3	us-gaap	Inventory Write Down InventoryWriteDown	46050	usd
CY2024Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	605470	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	605470	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3754853	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7600360	usd
CY2024Q3	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	1416654	usd
CY2024Q2	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	1268288	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2338199	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2356556	usd
CY2024Q3	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	239905	usd
CY2023Q3	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	194497	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10018484	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9797803	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	220681	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	19190	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1186800	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10018484	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9778613	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	239871	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	57568	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	76758	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	76758	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	9597	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	220681	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	390810	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	502188	usd
CY2024Q3	upxi	Description Of Lease Term DescriptionOfLeaseTerm	Our lease terms may include one or more options to extend the lease terms, for periods from one year to 20 years
CY2024Q3	upxi	Operating Leases Minimum Payments OperatingLeasesMinimumPayments	0	usd
CY2023Q3	upxi	Operating Leases Minimum Payments OperatingLeasesMinimumPayments	32850	usd
CY2024Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	1910	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	1910	usd
CY2024Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	853420	usd
CY2024Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	770004	usd
CY2024Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	507343	usd
CY2024Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	486733	usd
CY2024Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	221715	usd
CY2024Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	2839215	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	214900	usd
CY2024Q3	upxi	Accrued Adverse Lease Obligation AccruedAdverseLeaseObligation	2624315	usd
CY2024Q3	upxi	Less Current Portion LessCurrentPortion	-781810	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1842505	usd
CY2024Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P45M
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2023Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P44M
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	185148	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	170970	usd
CY2024Q3	us-gaap	Interest Expense Other InterestExpenseOther	28853	usd
CY2023Q3	us-gaap	Interest Expense Other InterestExpenseOther	26347	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	3784	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	4803	usd
CY2024Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	174212	usd
CY2024Q3	us-gaap	Variable Lease Cost VariableLeaseCost	51835	usd
CY2023Q3	us-gaap	Variable Lease Cost VariableLeaseCost	29084	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	269621	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	405416	usd
CY2024Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	169222	usd
CY2024Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	312500	usd
CY2024Q3	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	25394	usd
CY2024Q2	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	28539	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	111483	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	395368	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	306099	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	736407	usd
CY2024Q3	us-gaap	Acquisition Costs Cumulative AcquisitionCostsCumulative	0	usd
CY2024Q2	us-gaap	Acquisition Costs Cumulative AcquisitionCostsCumulative	413152	usd
CY2022Q2	us-gaap	Debt Instrument Increase Decrease For Period Net DebtInstrumentIncreaseDecreaseForPeriodNet	1500000	usd
CY2022Q2	us-gaap	Short Term Debt Interest Rate Increase ShortTermDebtInterestRateIncrease	0.085	pure
CY2022Q2	upxi	Additional Percentage Rate AdditionalPercentageRate	0.035	pure
CY2024Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	25081	shares
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	500000	usd
CY2024Q1	upxi	Common Stock Per Share Price CommonStockPerSharePrice	19.94
CY2024Q1	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan	5000	shares
CY2024Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	85000	usd
CY2024Q1	upxi	Common Stocks Par Or Stated Value Per Share CommonStocksParOrStatedValuePerShare	17
CY2024Q4	upxi	Reverse Stock Split Rate ReverseStockSplitRate	20 to 1
CY2024Q4	upxi	Total Issued And Outstanding Common Stock Shares Post Reverse Split TotalIssuedAndOutstandingCommonStockSharesPostReverseSplit	1040886	shares
CY2024Q3	upxi	Income Tax Expense Benefit Reserve IncomeTaxExpenseBenefitReserve	1	pure
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	472367	usd
CY2024Q3	upxi	Ffective Income Tax Rate ffectiveIncomeTaxRate	0.2583	pure
CY2022Q2	upxi	Valuation Reserves For Inventory ValuationReservesForInventory	2506514	usd
CY2024Q2	upxi	Valuation Reserves For Inventory ValuationReservesForInventory	6100000	usd
CY2024Q3	upxi	Valuation Reserves For Inventory ValuationReservesForInventory	6535000	usd

Files In Submission

Name	View Source	Status
0001477932-24-008219-index-headers.html	Edgar Link	pending
0001477932-24-008219-index.html	Edgar Link	pending
0001477932-24-008219.txt	Edgar Link	pending
0001477932-24-008219-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
upxi-20240930.xsd	Edgar Link	pending
upxi_10q.htm	Edgar Link	pending
upxi-20240930_cal.xml	Edgar Link	unprocessable
upxi-20240930_def.xml	Edgar Link	unprocessable
upxi-20240930_lab.xml	Edgar Link	unprocessable
upxi-20240930_pre.xml	Edgar Link	unprocessable
upxi_10q_htm.xml	Edgar Link	completed
upxi_ex311.htm	Edgar Link	pending
upxi_ex312.htm	Edgar Link	pending
upxi_ex321.htm	Edgar Link	pending
upxi_ex322.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UPXI
UPEXI, INC. Stock $upxi

2024 Q3 Form 10-Q Financial Statement

#000147793224008219 Filed on December 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UPXI UPEXI, INC. Stock $upxi

2024 Q3 Form 10-Q Financial Statement

#000147793224008219 Filed on December 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UPXI
UPEXI, INC. Stock $upxi